title: [Imagery of treated prostate cancer].
abstract: BACKGROUND
  Diagnosis, localization of recurrence in the management of prostate cancer patients with increasing concentrations of tumor serum markers is crucial for treatment planning of the patients. The present review describes the role of prostate MRI and (18) Fcholine PET/computed tomography (CT) in tumor detection and extent, when there is a suspicion of residual or recurrent disease after treatment of prostate cancer.
  
  
  METHODS
  A systematic review of the literature was performed by searching in the PUB MED/MEDLINE database searching for articles in French or English published between the last 12years.
  
  
  RESULTS
  In patient with a clinical suspicion of recurrence after treatment for prostate cancer, imaging can be used to distinguish between local recurrence and metastatic disease. (11)C-choline PET/CT and pelvic multiparametric MR imaging (mp MRI) are complementary in this indication. In this paper, the current status of imaging techniques used for the staging of patients with suspected locally recurrent or metastatic disease in patients treated for prostate cancer were reviewed.
  
  
  CONCLUSIONS
  Mp MRI of the prostate may be valuable imaging modality for the detection and localization of local recurrence. C-choline PET/CT offers an advantage in detecting metastatic disease to lymph node and bone.
authors.affiliation: Hôpital Pitié-Salpêtrière, 47, boulevard de l'Hôpital, 75013 Paris, France. Electronic address: raphaele.renardpenna@gmail.com.
authors.forename: R
authors.initials: R
authors.lastname: Renard-Penna
authors.affiliation: Hôpital Tenon, 4, rue de la Chine, 75200 Paris, France.
authors.forename: L
authors.initials: L
authors.lastname: Michaud
authors.affiliation: CHU de Dijon, 1, boulevard Jeanne-d'Arc, 21000 Dijon, France.
authors.forename: L
authors.initials: L
authors.lastname: Cormier
authors.affiliation: Hôpital Nord, CHU de Marseille, 416, chemin Madrague-Ville, 13015 Marseille, France.
authors.forename: C
authors.initials: C
authors.lastname: Bastide
authors.affiliation: Institut Curie, 26, rue Ulm, 75005 Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Beuzeboc
authors.affiliation: CHU Bretonneau, 2, boulevard Tonnellé, 37000 Tours, France.
authors.forename: G
authors.initials: G
authors.lastname: Fromont
authors.affiliation: Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Hennequin
authors.affiliation: Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Mongiat-Artus
authors.affiliation: Hôpital Cochin, 27, rue Faubourg-Saint-Jacques, 75014 Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Peyromaure
authors.affiliation: Institut Montsouris, université Paris-Descartes, 42, boulevard Jourdan, 75014 Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Rozet
authors.affiliation: Institut Bergonié, 229, cours Argonne, 33000 Bordeaux, France.
authors.forename: P
authors.initials: P
authors.lastname: Richaud
authors.affiliation: Hôpital Henri-Mondor, 51, avenue Maréchal-de-Lattre-de-Tassigny, 94000 Créteil, France.
authors.forename: L
authors.initials: L
authors.lastname: Salomon
authors.affiliation: Hôpital de Rangueil, CHU de Toulouse, 1, avenue Prof.-Jean-Poulhès, 31059 Toulouse cedex 9, France.
authors.forename: M
authors.initials: M
authors.lastname: Soulié
mesh_terms: D002794:Choline / Q000031:analogs & derivatives; D005462:Fluorine Radioisotopes; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D064847:Multimodal Imaging; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D049268:Positron-Emission Tomography; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy; D014057:Tomography, X-Ray Computed
chemical_list: D005462:Fluorine Radioisotopes; C516370:fluoromethylcholine; D002794:Choline
keywords: Cancer; IRM; MRI; PET/CT; PET/TDM; Prostate; Recurrence; Récidive